NASDAQ:APDN

Applied DNA Sciences Competitors

Notice: Trading of Applied DNA Sciences halted at 01:15 AM EST due to "LULD pause".
$6.63
-0.47 (-6.62 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.55
Now: $6.63
$7.81
50-Day Range
$7.08
MA: $8.30
$11.14
52-Week Range
$3.92
Now: $6.63
$16.39
Volume2.12 million shs
Average Volume1.47 million shs
Market Capitalization$49.55 million
P/E RatioN/A
Dividend YieldN/A
Beta1.4

Competitors

Applied DNA Sciences (NASDAQ:APDN) Vs. GENC, MNTX, LIQT, EML, IDN, and CLIR

Should you be buying APDN stock or one of its competitors? Companies in the sector of "industrial products" are considered alternatives and competitors to Applied DNA Sciences, including Gencor Industries (GENC), Manitex International (MNTX), LiqTech International (LIQT), The Eastern (EML), Intellicheck (IDN), and ClearSign Technologies (CLIR).

Gencor Industries (NASDAQ:GENC) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation.

Volatility & Risk

Gencor Industries has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Applied DNA Sciences has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for Gencor Industries and Applied DNA Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Gencor Industries0000N/A
Applied DNA Sciences00303.00

Applied DNA Sciences has a consensus target price of $19.6667, suggesting a potential upside of 196.63%. Given Applied DNA Sciences' higher probable upside, analysts clearly believe Applied DNA Sciences is more favorable than Gencor Industries.

Insider & Institutional Ownership

49.2% of Gencor Industries shares are owned by institutional investors. Comparatively, 7.0% of Applied DNA Sciences shares are owned by institutional investors. 29.2% of Gencor Industries shares are owned by insiders. Comparatively, 6.6% of Applied DNA Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Gencor Industries and Applied DNA Sciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Gencor Industries$77.42 million2.40$5.53 millionN/AN/A
Applied DNA Sciences$1.93 million25.67$-13,030,000.00($3.32)-2.00

Gencor Industries has higher revenue and earnings than Applied DNA Sciences.

Profitability

This table compares Gencor Industries and Applied DNA Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Gencor Industries7.54%3.47%3.24%
Applied DNA Sciences-672.79%-179.48%-109.47%

Summary

Gencor Industries beats Applied DNA Sciences on 8 of the 12 factors compared between the two stocks.

Manitex International (NASDAQ:MNTX) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation.

Valuation & Earnings

This table compares Manitex International and Applied DNA Sciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Manitex International$224.78 million0.78$-8,490,000.00$0.1559.20
Applied DNA Sciences$1.93 million25.67$-13,030,000.00($3.32)-2.00

Manitex International has higher revenue and earnings than Applied DNA Sciences. Applied DNA Sciences is trading at a lower price-to-earnings ratio than Manitex International, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and target prices for Manitex International and Applied DNA Sciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Manitex International00103.00
Applied DNA Sciences00303.00

Manitex International currently has a consensus target price of $10.00, suggesting a potential upside of 12.61%. Applied DNA Sciences has a consensus target price of $19.6667, suggesting a potential upside of 196.63%. Given Applied DNA Sciences' higher probable upside, analysts clearly believe Applied DNA Sciences is more favorable than Manitex International.

Profitability

This table compares Manitex International and Applied DNA Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Manitex International-7.08%-0.40%-0.15%
Applied DNA Sciences-672.79%-179.48%-109.47%

Insider & Institutional Ownership

49.5% of Manitex International shares are owned by institutional investors. Comparatively, 7.0% of Applied DNA Sciences shares are owned by institutional investors. 6.7% of Manitex International shares are owned by insiders. Comparatively, 6.6% of Applied DNA Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Volatility & Risk

Manitex International has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Applied DNA Sciences has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.

Summary

Manitex International beats Applied DNA Sciences on 8 of the 13 factors compared between the two stocks.

Applied DNA Sciences (NASDAQ:APDN) and LiqTech International (NASDAQ:LIQT) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Applied DNA Sciences and LiqTech International's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied DNA Sciences$1.93 million25.67$-13,030,000.00($3.32)-2.00
LiqTech International$32.64 million5.38$40,000.00N/AN/A

LiqTech International has higher revenue and earnings than Applied DNA Sciences.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Applied DNA Sciences and LiqTech International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied DNA Sciences00303.00
LiqTech International01102.50

Applied DNA Sciences presently has a consensus target price of $19.6667, suggesting a potential upside of 196.63%. LiqTech International has a consensus target price of $11.00, suggesting a potential upside of 35.97%. Given Applied DNA Sciences' stronger consensus rating and higher probable upside, research analysts plainly believe Applied DNA Sciences is more favorable than LiqTech International.

Profitability

This table compares Applied DNA Sciences and LiqTech International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied DNA Sciences-672.79%-179.48%-109.47%
LiqTech International-28.10%-28.05%-17.33%

Insider and Institutional Ownership

7.0% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 57.5% of LiqTech International shares are owned by institutional investors. 6.6% of Applied DNA Sciences shares are owned by insiders. Comparatively, 2.8% of LiqTech International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk and Volatility

Applied DNA Sciences has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, LiqTech International has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.

Summary

Applied DNA Sciences beats LiqTech International on 7 of the 13 factors compared between the two stocks.

Applied DNA Sciences (NASDAQ:APDN) and The Eastern (NASDAQ:EML) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Applied DNA Sciences and The Eastern's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied DNA Sciences$1.93 million25.67$-13,030,000.00($3.32)-2.00
The Eastern$251.74 million0.65$13.27 millionN/AN/A

The Eastern has higher revenue and earnings than Applied DNA Sciences.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Applied DNA Sciences and The Eastern, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied DNA Sciences00303.00
The Eastern10001.00

Applied DNA Sciences presently has a consensus target price of $19.6667, suggesting a potential upside of 196.63%. Given Applied DNA Sciences' stronger consensus rating and higher probable upside, research analysts plainly believe Applied DNA Sciences is more favorable than The Eastern.

Profitability

This table compares Applied DNA Sciences and The Eastern's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied DNA Sciences-672.79%-179.48%-109.47%
The Eastern3.60%12.08%4.59%

Insider and Institutional Ownership

7.0% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 65.0% of The Eastern shares are owned by institutional investors. 6.6% of Applied DNA Sciences shares are owned by insiders. Comparatively, 14.3% of The Eastern shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk and Volatility

Applied DNA Sciences has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, The Eastern has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500.

Summary

The Eastern beats Applied DNA Sciences on 8 of the 13 factors compared between the two stocks.

Applied DNA Sciences (NASDAQ:APDN) and Intellicheck (NASDAQ:IDN) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Applied DNA Sciences and Intellicheck's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied DNA Sciences$1.93 million25.67$-13,030,000.00($3.32)-2.00
Intellicheck$7.66 million20.78$-2,550,000.00($0.16)-53.50

Intellicheck has higher revenue and earnings than Applied DNA Sciences. Intellicheck is trading at a lower price-to-earnings ratio than Applied DNA Sciences, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Applied DNA Sciences and Intellicheck, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied DNA Sciences00303.00
Intellicheck00203.00

Applied DNA Sciences presently has a consensus target price of $19.6667, suggesting a potential upside of 196.63%. Intellicheck has a consensus target price of $16.50, suggesting a potential upside of 92.76%. Given Applied DNA Sciences' higher probable upside, research analysts plainly believe Applied DNA Sciences is more favorable than Intellicheck.

Profitability

This table compares Applied DNA Sciences and Intellicheck's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied DNA Sciences-672.79%-179.48%-109.47%
Intellicheck-5.64%-3.57%-3.06%

Insider and Institutional Ownership

7.0% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 47.5% of Intellicheck shares are owned by institutional investors. 6.6% of Applied DNA Sciences shares are owned by insiders. Comparatively, 8.8% of Intellicheck shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk and Volatility

Applied DNA Sciences has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Intellicheck has a beta of 2.23, meaning that its share price is 123% more volatile than the S&P 500.

Summary

Intellicheck beats Applied DNA Sciences on 9 of the 13 factors compared between the two stocks.

Applied DNA Sciences (NASDAQ:APDN) and ClearSign Technologies (NASDAQ:CLIR) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Applied DNA Sciences and ClearSign Technologies' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied DNA Sciences$1.93 million25.67$-13,030,000.00($3.32)-2.00
ClearSign Technologies$530,000.00267.03$-8,480,000.00($0.32)-14.31

ClearSign Technologies has lower revenue, but higher earnings than Applied DNA Sciences. ClearSign Technologies is trading at a lower price-to-earnings ratio than Applied DNA Sciences, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Applied DNA Sciences and ClearSign Technologies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied DNA Sciences00303.00
ClearSign Technologies00103.00

Applied DNA Sciences presently has a consensus target price of $19.6667, suggesting a potential upside of 196.63%. ClearSign Technologies has a consensus target price of $10.00, suggesting a potential upside of 118.34%. Given Applied DNA Sciences' higher probable upside, research analysts plainly believe Applied DNA Sciences is more favorable than ClearSign Technologies.

Profitability

This table compares Applied DNA Sciences and ClearSign Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied DNA Sciences-672.79%-179.48%-109.47%
ClearSign TechnologiesN/A-77.84%-63.93%

Insider and Institutional Ownership

7.0% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 8.1% of ClearSign Technologies shares are owned by institutional investors. 6.6% of Applied DNA Sciences shares are owned by insiders. Comparatively, 25.6% of ClearSign Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Risk and Volatility

Applied DNA Sciences has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, ClearSign Technologies has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500.

Summary

ClearSign Technologies beats Applied DNA Sciences on 8 of the 13 factors compared between the two stocks.


Applied DNA Sciences Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Gencor Industries logo
GENC
Gencor Industries
0.8$12.72-2.3%$185.79 million$77.42 million33.47News Coverage
Manitex International logo
MNTX
Manitex International
1.3$8.88-2.7%$176.01 million$224.78 million-13.87
LiqTech International logo
LIQT
LiqTech International
1.4$8.09-1.6%$175.53 million$32.64 million-24.51
EML
The Eastern
1.1$26.07-1.2%$162.89 million$251.74 million18.23
Intellicheck logo
IDN
Intellicheck
1.9$8.56-2.5%$159.17 million$7.66 million-214.00
ClearSign Technologies logo
CLIR
ClearSign Technologies
1.3$4.58-9.4%$141.53 million$530,000.00-19.08
Graham logo
GHM
Graham
1.9$13.85-3.2%$138.35 million$90.60 million92.33
WISeKey International logo
WKEY
WISeKey International
1.4$10.08-4.7%$134.85 million$22.65 million-3.15
Twin Disc logo
TWIN
Twin Disc
1.2$9.87-1.2%$134.67 million$246.84 million-3.48
Ampco-Pittsburgh logo
AP
Ampco-Pittsburgh
0.7$6.90-3.8%$130.05 million$397.90 million10.00
Digital Ally logo
DGLY
Digital Ally
1.2$2.03-14.8%$104.59 million$10.44 million-4.32High Trading Volume
Gap Down
Capstone Turbine logo
CPST
Capstone Turbine
1.1$8.08-6.4%$103.62 million$68.93 million-4.30News Coverage
Advanced Emissions Solutions logo
ADES
Advanced Emissions Solutions
0.9$5.28-1.1%$97.78 million$70.09 million-8.00
Magal Security Systems logo
MAGS
Magal Security Systems
0.9$4.16-3.6%$96.32 million$86.83 million46.22
Perma-Fix Environmental Services logo
PESI
Perma-Fix Environmental Services
0.6$7.58-0.5%$92.22 million$73.46 million23.69
Broadwind logo
BWEN
Broadwind
1.6$5.34-6.6%$91.46 million$178.22 million-88.99
ARC Document Solutions logo
ARC
ARC Document Solutions
1.2$2.13-5.6%$91.15 million$382.42 million15.21
Houston Wire & Cable logo
HWCC
Houston Wire & Cable
0.7$5.25-0.2%$88.64 million$338.29 million-29.17
Synalloy logo
SYNL
Synalloy
0.6$9.61-1.1%$88.46 million$305.17 million-4.45
Hudson Technologies logo
HDSN
Hudson Technologies
0.7$2.03-1.0%$88.00 million$162.06 million-7.81
Fuel Tech logo
FTEK
Fuel Tech
0.5$2.57-10.9%$77.76 million$30.47 million-8.86
Vertex Energy logo
VTNR
Vertex Energy
1.3$1.39-11.5%$71.92 million$163.37 million-2.53
RSSS
Research Solutions
0.0$2.45-0.0%$64.38 million$31.06 million-81.67
Ideal Power logo
IPWR
Ideal Power
1.1$10.52-7.3%$61.77 millionN/A-4.70
Perma-Pipe International logo
PPIH
Perma-Pipe International
0.6$6.15-2.9%$50.20 million$127.66 million-13.66News Coverage
Gap Up
Vinco Ventures logo
BBIG
Vinco Ventures
0.0$2.57-2.3%$48.71 million$19.63 million-1.50News Coverage
APWC
Asia Pacific Wire & Cable
0.6$3.46-6.6%$47.81 million$338.20 million0.00
Taylor Devices logo
TAYD
Taylor Devices
0.9$12.21-3.3%$42.60 million$28.38 million16.50
Pioneer Power Solutions logo
PPSI
Pioneer Power Solutions
0.5$3.98-12.6%$34.75 million$20.58 million0.00Gap Up
FFHL
Fuwei Films
0.8$10.58-0.2%$34.55 million$48.21 million4.72Gap Up
CVD Equipment logo
CVV
CVD Equipment
0.5$4.49-1.3%$30.00 million$19.65 million0.00
SuperCom logo
SPCB
SuperCom
0.6$1.57-1.9%$29.48 million$16.48 million0.00Gap Up
SMIT
Schmitt Industries
0.4$7.75-7.4%$29.47 million$4.19 million-9.69Upcoming Earnings
High Trading Volume
Gap Down
IKONICS logo
IKNX
IKONICS
0.5$10.36-5.4%$20.48 million$17.62 million-10.26Gap Down
CLWT
Euro Tech
0.9$2.97-2.7%$15.30 million$17.40 million0.00
Art's-Way Manufacturing logo
ARTW
Art's-Way Manufacturing
0.7$3.15-8.9%$14.37 million$22.89 million-7.50
HIHO
Highway
0.9$3.50-3.1%$13.90 million$12.56 million15.91
CTIB
Yunhong CTI
0.7$2.22-1.4%$12.84 million$40.54 million0.00
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.